glp-1 multiple sclerosis 2024 Highlight GLP-1 Receptor Agonist Use Associated
Description
If youd like to notify the FDA about a side effect youve had with Januvia, visit MedWatch
[15] However, subsequent analysis revealed important context: the increased risk was predominantly observed in patients with pre-existing diabetic retinopathy and those who experienced rapid improvements in glycaemic control
But regulators, payers, and companies must balance innovation incentives with public health considerations
Blonde L, Jendle J, Gross J, Woo V, Jiang H, Fahrbach JL, et al
doi: 10.3390/ijms22042110 [DOI] [PMC free article] [PubMed] [Google Scholar] 79
Yes , you can switch between GLP-1 medications
